Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Werner Poewe

Showing results (551-560 of 602) with videos related to

Pageof 61
Sort By:
Parkinsonism & Related Disorders|June 19, 2018
Axial motor clues to identify atypical parkinsonism: A multicentre European cohort studyCarlijn D J M Borm, Florian Krismer, Gregor K Wenning, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 15, 2005
Progression of multiple system atrophy (MSA): a prospective natural history study by the European MSA Study Group (EMSA SG)Felix Geser, Gregor K Wenning, Klaus Seppi, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 23, 2006
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing planChristopher G Goetz, Stanley Fahn, Pablo Martinez-Martin, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 31, 2022
Optimal deep brain stimulation sites and networks for cervical vs. generalized dystoniaAndreas Horn, Martin M Reich, Siobhan Ewert, et al.
Brain : a Journal of Neurology|April 15, 2021
Alpha-synuclein seeds in olfactory mucosa of patients with isolated REM sleep behaviour disorderAmbra Stefani, Alex Iranzo, Evi Holzknecht, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 3, 2014
The onset of nonmotor symptoms in Parkinson's disease (the ONSET PD study)Claustre Pont-Sunyer, Anna Hotter, Carles Gaig, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 12, 2015
Diffusion imaging of nigral alterations in early Parkinson's disease with dopaminergic deficitsNorbert Schuff, I-Wei Wu, Shannon Buckley, et al.
Frontiers in Neurology|October 18, 2021
A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline DataGennaro Pagano, Frank G Boess, Kirsten I Taylor, et al.
The Lancet. Neurology|March 18, 2024
Safety and efficacy of continuous subcutaneous levodopa-carbidopa infusion (ND0612) for Parkinson's disease with motor fluctuations (BouNDless): a phase 3, randomised, double-blind, double-dummy, multicentre trialAlberto J Espay, Fabrizio Stocchi, Rajesh Pahwa, et al.
Journal of Neurology|January 5, 2013
Selecting deep brain stimulation or infusion therapies in advanced Parkinson's disease: an evidence-based reviewJens Volkmann, Alberto Albanese, Angelo Antonini, et al.
Pageof 61

Showing results (551-560 of 602) with videos related to

Sort By:
Pageof 61
Parkinsonism & Related Disorders|June 19, 2018
Axial motor clues to identify atypical parkinsonism: A multicentre European cohort studyCarlijn D J M Borm, Florian Krismer, Gregor K Wenning, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 15, 2005
Progression of multiple system atrophy (MSA): a prospective natural history study by the European MSA Study Group (EMSA SG)Felix Geser, Gregor K Wenning, Klaus Seppi, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 23, 2006
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing planChristopher G Goetz, Stanley Fahn, Pablo Martinez-Martin, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 31, 2022
Optimal deep brain stimulation sites and networks for cervical vs. generalized dystoniaAndreas Horn, Martin M Reich, Siobhan Ewert, et al.
Brain : a Journal of Neurology|April 15, 2021
Alpha-synuclein seeds in olfactory mucosa of patients with isolated REM sleep behaviour disorderAmbra Stefani, Alex Iranzo, Evi Holzknecht, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 3, 2014
The onset of nonmotor symptoms in Parkinson's disease (the ONSET PD study)Claustre Pont-Sunyer, Anna Hotter, Carles Gaig, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 12, 2015
Diffusion imaging of nigral alterations in early Parkinson's disease with dopaminergic deficitsNorbert Schuff, I-Wei Wu, Shannon Buckley, et al.
Frontiers in Neurology|October 18, 2021
A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline DataGennaro Pagano, Frank G Boess, Kirsten I Taylor, et al.
The Lancet. Neurology|March 18, 2024
Safety and efficacy of continuous subcutaneous levodopa-carbidopa infusion (ND0612) for Parkinson's disease with motor fluctuations (BouNDless): a phase 3, randomised, double-blind, double-dummy, multicentre trialAlberto J Espay, Fabrizio Stocchi, Rajesh Pahwa, et al.
Journal of Neurology|January 5, 2013
Selecting deep brain stimulation or infusion therapies in advanced Parkinson's disease: an evidence-based reviewJens Volkmann, Alberto Albanese, Angelo Antonini, et al.
Pageof 61